ライフサイエンスコーパス: caffeinated

1 ed coffee in the NHS (P < 0.0001) and 4% for caffeinated and 7% for decaffeinated coffee in the HPFS

2 Consumption of caffeinated and artificially sweetened soft drinks was p

3 nd dietary risk factors were controlled for, caffeinated and caffeine-free SSB intake was significant

4 High intake of caffeinated and decaffeinated coffee (2 or more cups/day

5 als Follow-up Study, we associated intake of caffeinated and decaffeinated coffee after diagnosis of

6 e encouraged to completely abstain from both caffeinated and decaffeinated coffee and other caffeine-

7 The association between consumption of caffeinated and decaffeinated coffee and risk of mortali

8 ver the past 4 y concluded that ingestion of caffeinated and decaffeinated coffee can reduce the risk

9 ve study aimed to examine the consumption of caffeinated and decaffeinated coffee in relation to card

10 wer risk of T2D [RR per serving: 8% for both caffeinated and decaffeinated coffee in the NHS (P < 0.0

11 After adjustment for caffeinated and decaffeinated coffee intake amounts, sle

12 This study examined the association of caffeinated and decaffeinated coffee intake with cogniti

13 Conversely, the consumption of caffeinated and decaffeinated coffee was associated with

14 Trends were similar between caffeinated and decaffeinated coffee.

15 was to assess the relation between long-term caffeinated and decaffeinated filtered coffee consumptio

16 We evaluated coffee and tea intakes (caffeinated and decaffeinated) in relation to colon (pro

17 spective associations between consumption of caffeinated and noncaffeinated sugar- and artificially s

18 Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly a

19 ed the associations of consumption of total, caffeinated, and decaffeinated coffee with risk of subse

20 The final sample for caffeinated beverage analyses included 2583 women.

21 and mortality in aging, we hypothesized that caffeinated beverage consumption decreases the risk of c

22 xamined the association between caffeine and caffeinated beverage consumption in relation to the risk

23 caffeine and paraxanthine and self-reported caffeinated beverage consumption measured/reported at 10

24 Coffee is the most commonly consumed caffeinated beverage in the US, and a randomized trial a

25 e assessed the relation between caffeine and caffeinated beverage intake and reproductive hormones in

26 ephone interview collected information about caffeinated beverage intake as well as other lifestyle,

27 Preconception self-reported caffeinated beverage intake compared to no intake was as

28 Participants aged >or=65 y with higher caffeinated beverage intake exhibited lower relative ris

29 Findings support recommendations to limit caffeinated beverage intake for LUTS, and in men, they s

30 evant mechanism for the protective effect of caffeinated beverage intake in human epidemiologic studi

31 In parallel, self-reported caffeinated beverage intake was captured via administrat

32 In this cohort study, second trimester caffeinated beverage intake within current recommendatio

33 en preconception serum caffeine metabolites, caffeinated beverage intake, and fecundability.

34 at baseline, and time-varying cycle-average caffeinated beverage intake, with fecundability.

35 feine and its metabolites, and self-reported caffeinated beverage intake, with multiple measures of n

36 e mortality than did participants with lower caffeinated beverage intake.

37 a specific time of day, self-reported usual caffeinated beverage intakes at baseline, and time-varyi

38 (24HDRs) for measuring monthly caffeine and caffeinated beverage intakes; and 2) validity of the 24H

39 ding to their reported current and long-time caffeinated beverage use into one of three groups: low [

40 nalysis revealed that oral administration of caffeinated beverages (green tea, black tea, decaffeinat

41 en the common consumption of coffee or other caffeinated beverages and a reduced risk of developing P

42 nted on the association between caffeine and caffeinated beverages and reproductive hormones and whet

43 occupy up to 50% of the cerebral A(1)AR when caffeinated beverages are repeatedly consumed during a d

44 Caffeinated beverages are widely consumed among women of

45 tudy data to test whether the consumption of caffeinated beverages exhibits this protective effect.

46 Caffeinated beverages have become a common dietary habit

47 Habitual intake of caffeinated beverages provided protection against the ri

48 Consumption of caffeinated beverages such as coffee and tea has been as

49 Baseline intake of total caffeinated beverages was not associated with fecundabil

50 ks, 1073 women (41.5%) reported consuming no caffeinated beverages, 1317 (51.0%) reported consuming 1

51 eks, 599 women (23.6%) reported consuming no caffeinated beverages, 1734 (68.3%) reported consuming 1

52 Compared with women who reported drinking no caffeinated beverages, women who consumed approximately

53 ption of carbonated beverages is confined to caffeinated beverages.

54 uestions on the use of tobacco, alcohol, and caffeinated beverages.

55 gas chromatography of each subject's brewed, caffeinated beverages.

56 (0.8%) reported consuming more than 200 mg/d caffeinated beverages.

57 Multiple human epidemiologic studies link caffeinated (but not decaffeinated) beverage intake with

58 sted FOR: 0.99; 95% CI: 0.74, 1.34), nor was caffeinated coffee (>2 compared with 0 servings/d adjust

59 ncreasing categories of consistent intake of caffeinated coffee (0, 1, 2-3, and > or =4 cups/day) wer

60 isk of injurious falls among those consuming caffeinated coffee (HR: 0.83; 95% CI: 0.68, 1.00 for 1 c

61 mol/l among women consuming >/=4 cups/day of caffeinated coffee and 23.0 nmol/l among nondrinkers (P

62 Caffeinated coffee and daily caffeine intake were not as

63 duced shortly after ingestion of caffeine or caffeinated coffee and suggesting that coffee consumptio

64 rrhythmia were all more likely to drink less caffeinated coffee and to be non-habitual or decaffeinat

65 The consumption of caffeinated coffee as compared with no caffeine consumpt

66 cardioversion, allocation to consumption of caffeinated coffee averaging 1 cup a day was associated

67 iabetes for women consuming >/=4 cups/day of caffeinated coffee compared with nondrinkers was 0.47 (9

68 69 [11] years; 71% male) were randomized to caffeinated coffee consumption (n = 100) or coffee absti

69 rd lower risk of stroke after adjustment for caffeinated coffee consumption (RR for >or=2 cups a day

70 s to assess the association between filtered caffeinated coffee consumption and all-cause and CVD mor

71 t inverse association was also found between caffeinated coffee consumption and BCC risk.

72 there was no relationship between cumulative caffeinated coffee consumption and RA risk (RR 1.1, 95%

73 igher SBP and DBP were associated with lower caffeinated coffee consumption at baseline, with consist

74 in the US, and a randomized trial assessing caffeinated coffee consumption in patients with atrial f

75 ts were randomized in a 1:1 ratio to regular caffeinated coffee consumption vs coffee and caffeine ab

76 In women with type 2 diabetes, higher caffeinated coffee consumption was associated with lower

77 to abstainers, those who drank >/= 3 cups of caffeinated coffee daily were at increased risk of EG/EG

78 ver, for consumption of five or more cups of caffeinated coffee daily, the RR was 1.61 (95% CI, 1.00-

79 p were encouraged to drink at least 1 cup of caffeinated coffee daily.

80 In this randomized trial, the consumption of caffeinated coffee did not result in significantly more

81 Patients consuming 4 cups/d or more of caffeinated coffee experienced significantly reduced can

82 lele of SHBG gene consuming >/=2 cups/day of caffeinated coffee had lower risk of type 2 diabetes in

83 Caffeine and caffeinated coffee have been shown to acutely increase b

84 n were measured after 14 d of consumption of caffeinated coffee high in chlorogenic acid (C-HCA), dec

85 p of participants with a low or no intake of caffeinated coffee in the HPFS cohort.

86 High caffeinated coffee intake also was not associated with r

87 Women reported less caffeinated coffee intake in their 24HDRs compared with

88 two other cognitive function tests; current caffeinated coffee intake was associated with better per

89 In this large prospective study, caffeinated coffee intake was inversely associated with

90 prior day's diary record for measuring daily caffeinated coffee intake.

91 the markers were found across categories of caffeinated coffee intake.

92 Conventional wisdom holds that caffeinated coffee is proarrhythmic.

93 Compared with individuals who consumed caffeinated coffee less than 1 cup per month, women who

94 These data suggest that consumption of caffeinated coffee may play a role in the prevention of

95 Neither caffeinated coffee nor caffeine intake was associated wi

96 se-crossover trial to examine the effects of caffeinated coffee on cardiac ectopy and arrhythmias, da

97 ese analyses indicate a beneficial impact of caffeinated coffee on liver morphology and/or function,

98 American women who drink moderate amounts of caffeinated coffee or alcohol have a reduced risk of typ

99 to randomly instruct participants to consume caffeinated coffee or avoid caffeine.

100 feinated coffee per day], moderate (3-4 cups caffeinated coffee per day), or high (> or = 5 cups caff

101 ated coffee per day), or high (> or = 5 cups caffeinated coffee per day).

102 ups: low [0-2 cups (180 mL, or 6 oz per cup) caffeinated coffee per day], moderate (3-4 cups caffeina

103 Caffeinated coffee showed significant inverse associatio

104 odds ratio for drinking > or = 4 cups/day of caffeinated coffee versus drinking < or = 1 cup/week was

105 The consumption of caffeinated coffee was associated with 58 daily prematur

106 Intake of >4 cups/day of caffeinated coffee was associated with a 49% lower risk

107 Consumption of filtered caffeinated coffee was not associated with CVD or all-ca

108 Caffeinated coffee was positively associated with SHBG b

109 The corresponding figures for caffeinated coffee were 0.67 (95% CI: 0.42, 1.07) and 0.

110 r each 240-ml (8-oz) serving consumed daily: caffeinated coffee, 10% (95% confidence interval 4-15%);

111 ving consumed daily: 10% (CI, 5% to 15%) for caffeinated coffee, 9% (CI, 2% to 15%) for decaffeinated

112 Higher consumption of total coffee, caffeinated coffee, and decaffeinated coffee was associa

113 and total caffeine intake (mg/d) or cups of caffeinated coffee, decaffeinated coffee, and caffeinate

114 In summary, these findings suggest that caffeinated coffee, decaffeinated coffee, and caffeine a

115 ined the associations of baseline intakes of caffeinated coffee, decaffeinated coffee, and caffeine w

116 The mean intakes of caffeinated coffee, decaffeinated coffee, and caffeine w

117 Intakes of caffeinated coffee, decaffeinated coffee, and caffeine w

118 The authors examined associations of caffeinated coffee, decaffeinated coffee, and tea intake

119 The authors investigated the association of caffeinated coffee, decaffeinated coffee, and tea with m

120 e sought to assess longitudinal relations of caffeinated coffee, decaffeinated coffee, and total caff

121 s based on self-reported past week intake of caffeinated coffee, tea, soda, and energy drinks.

122 women who consistently reported consuming no caffeinated coffee, the multivariate relative risks (adj

123 those overall for drinkers of predominantly caffeinated coffee.

124 for intakes of 0-1, 1, 2-3, and >/=4 cups of caffeinated coffee/d relative to no coffee intake were 0

125 , 19%) lower risk of stroke and 1 serving of caffeinated coffee/d with a 9% (95% CI: 0%, 17%) lower r

126 healthy women consumed > or =1 cup (237 mL) caffeinated coffee/mo and 75% consumed > or =1 cup decaf

127 % CI, 1.00-2.59; P for trend = 0.02); tea or caffeinated cola intake were not associated with risk.

128 to prospectively examine the association of caffeinated compared with caffeine-free beverages, inclu

129 We found that 24 hr of exposure to a caffeinated diet desensitized all of the caffeine-respon

130 recently increased soda intake, particularly caffeinated diet soda, had higher symptom scores, urgenc

131 Answer: No--at least, not in the brain of a caffeinated dopamine-deficient (DD) mutant mouse.

132 offee use was more prevalent than the use of caffeinated drinks and caffeine tablets.

133 behavioral proxy, such as average number of caffeinated drinks consumed per day.

134 in which the consumption of coffee and other caffeinated drinks was assessed starting in 1986 as part

135 were surveyed regarding their use of coffee, caffeinated drinks, and caffeine tablets for CE and pote

136 offee use; 24.2%, 15.4%, 9.9%, and 6.1%, for caffeinated drinks; and 12.6%, 5.9%, 4.7%, and 3.8%, res

137 epiness, many teens regularly consume highly caffeinated energy drinks and other stimulants, creating

138 In laboratory arena tests, we fed bees a caffeinated food alongside a floral odor blend (priming)

139 Caffeinated free-flying bees show enhanced learning perf

140 A lower risk of T2D was associated with caffeinated (HR: 0.77; 95% CI: 0.63, 0.94; P-trend 0.009

141 Caffeinated (HR: 0.94; 95% CI: 0.84, 1.05) or decaffeina

142 ssociations,(5) which could give plants with caffeinated nectar an adaptive advantage by inducing mor

143 d data, the wider ecological significance of caffeinated nectar remains difficult to interpret.

144 These results indicate that neither caffeinated nor decaffeinated filtered coffee has a detr

145 stantiate recommendations for restriction of caffeinated or acidic beverages as self-management for l

146 No association was observed between caffeinated or decaffeinated coffee consumption and risk

147 ctions in risk were seen for substitution of caffeinated or decaffeinated coffee for low-calorie soda

148 offee with additives.Drinking coffee, either caffeinated or decaffeinated, may lower the risk of CVD

149 icant inverse associations were observed for caffeinated (P value for trend < 0.001) and decaffeinate

150 find associations with consumption of other caffeinated products (caffeinated soda, caffeinated tea,

151 scontinued or substantially curtailed use of caffeinated products because of associated anxiety and d

152 However, evidence that the consumption of caffeinated products increases the risk of arrhythmias r

153 ter compared with abstinence from coffee and caffeinated products.

154 d adjusted FOR: 0.93; 95% CI: 0.45, 1.92) or caffeinated soda (>2 servings/d adjusted FOR: 0.92; 95%

155 ol concentrations among white women, whereas caffeinated soda and green tea intakes were associated w

156 o more than 2 cups of coffee or four cans of caffeinated soda daily), caffeine intake was positively

157 Caffeinated soda intake and green tea intake >/=1 cup/d

158 h consumption of other caffeinated products (caffeinated soda, caffeinated tea, decaffeinated coffee

159 examined the hypothesis that consumption of caffeinated soft drinks in childhood is associated with

160 percentage body fat, greater consumption of caffeinated soft drinks was associated with a higher ris

161 r drinks containing caffeine such as tea and caffeinated soft drinks were not associated with stroke.

162 m of brewed coffee, instant coffee, tea, and caffeinated soft drinks, as well as caffeine intoxicatio

163 k of T2D in the NHS (RR per serving: 13% for caffeinated SSBs, 11% for caffeine-free SSBs; P < 0.05)

164 05) and in the HPFS (RR per serving: 16% for caffeinated SSBs, 23% for caffeine-free SSBs; P < 0.01).

165 Surgeons often use caffeinated substances to cope with fatigue and long wor

166 formance(6) and are more likely to revisit a caffeinated target feeder or artificial flower,(7-9) alt

167 rviewers assessed self-reported usual weekly caffeinated tea consumption during the year before infar

168 Only caffeinated tea was associated with a lower T2D risk amo

169 ther caffeinated products (caffeinated soda, caffeinated tea, decaffeinated coffee or chocolate) and

170 affeinated coffee, decaffeinated coffee, and caffeinated tea.

171 fferentiate between decaffeinated and highly caffeinated yerba mate.